Table of Content


Chapter 1   Methodology & Scope
1.1    Market scope & definitions
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates & calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? Synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Increasing incidence of post-operative pain
3.2.1.2    Advancements in non-opioid pain management
3.2.1.3    Rising admissions in emergency and acute care departments
3.2.1.4    Advances in intravenous drug delivery technologies
3.2.2    Industry pitfalls & challenges
3.2.2.1    High cost compared to oral alternatives
3.2.2.2    Potential side effects and contraindications
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Technological landscape
3.6    Future market trends
3.7    Gap analysis
3.8    Porter’s analysis
3.9    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Competitive analysis of major market players
4.4    Competitive positioning matrix
4.5    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Conventional IV ibuprofen
5.3    High-concentration IV ibuprofen
Chapter 6   Market Estimates and Forecast, By Indication, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Pain management
6.3    Fever management
Chapter 7   Market Estimates and Forecast, By Age Group, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Pediatrics
7.3    Adults
Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Hospital pharmacies
8.3    Retail pharmacies
8.4    E-commerce
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Spain
9.3.5    Italy
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    AFT Pharmaceuticals
10.2    Al Nabeel International
10.3    Alveda Pharmaceuticals
10.4    CSL Limited
10.5    Cumberland Pharmaceuticals
10.6    Fresenius SE & Co. KGaA
10.7    Grifols
10.8    Harbin Gloria Pharmaceuticals
10.9    Hyloris Pharmaceuticals
10.10    Laboratorios Valmorca
10.11    Recordati
10.12    Sandor Medicaids
10.13    Soho Industri Pharmasi
10.14    Teligent
10.15    XGEN Pharmaceuticals